Stock IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Market Closed - Nasdaq
Other stock markets
 02:00:01 07/05/2024 am IST 		5-day change 1st Jan Change
23.14 USD -19.90% Intraday chart for Integra LifeSciences Holdings Corporation -20.86% -46.87%
01:58pm Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45 MT
01:42pm Oppenheimer Downgrades Integra LifeSciences Holdings to Perform From Outperform MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45
MT
Oppenheimer Downgrades Integra LifeSciences Holdings to Perform From Outperform
MT
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024
AQ
Integra LifeSciences : Asian American & Pacific Islander (AAPI) Heritage Month – Advancing Leaders Through Innovation
PU
Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings
DJ
Transcript : Integra LifeSciences Holdings Corporation, Q1 2024 Earnings Call, May 06, 2024
Integra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 Outlook
MT
North American Morning Briefing : Stock Futures -2-
DJ
Integra LifeSciences Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Reports Q1 Revenue $368.9M, vs. Street Est of $362M
MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q1 EPS $0.55, vs. Street Est of $0.55
MT
Integra: Q1 Earnings Snapshot
AQ
Integra LifeSciences Reports First Quarter 2024 Financial Results
AQ
Integra LifeSciences Holdings Corporation Provides Revenue Guidance for the Second Quarter and Full Year 2024
CI
Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
AQ
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
AQ
Integra LifeSciences : 46 Years of Creating Magnificent Instruments
PU
North American Morning Briefing : Focus Turns to -2-
DJ
Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target
MT
Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target is $38
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IART Stock
  4. News Integra LifeSciences Holdings Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW